Risk Adapted Therapy in Diffuse Large B Cell Lymphoma

NCT03188198 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Large B Cell Lymphoma

Interventions

DRUG: rituximab, etoposide, cyclophosphamide, doxorubicin, vincristine,prednisone, filgrastim

Sponsor

Mansoura University